State drug controllers must submit action-taken reports by 16 November as the regulator moves to ensure margin caps—which cut some therapy prices by over 90%—reach patients. New Delhi: The National Pharmaceutical Pricing Authority (NPPA) has ordered strict nationwide monitoring to ensure patients benefit from recent price reductions on 137 non-scheduled anti-cancer drugs.